Hypouricemia linked to an overproduction of nitric oxide is an early marker of oxidative stress in female subjects with type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 4, 2008, Pages 318-323

  Pitocco, Dario ^a   Di Stasio, Enrico ^a   Romitelli, Federica ^a   Zaccardi, Francesco ^a   Tavazzi, Barbara ^a   Manto, Andrea ^a   Caputo, Salvatore ^a   Musella, Tittania ^a   Zuppi, Cecilia ^a   Santini, Stefano A ^a   Ghirlanda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hyperglycemia; Hypouricemia; Nitric oxide; Oxidative stress; Type 1 diabetes

Indexed keywords

ASCORBIC ACID; BIOCHEMICAL MARKER; C PEPTIDE; HEMOGLOBIN A1C; INSULIN; NITRIC OXIDE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; HYPOURICEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINALYSIS; VENOUS BLOOD;

ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERURICEMIA; INSULIN; NITRIC OXIDE; OXIDATIVE STRESS; URIC ACID;

EID: 44949087734     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.814     Document Type: Article

References (33)

1. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36: 523-534.
2. Haffner SM, Letho S, Ronnamaa T, Pyorala K, Laakso M. Mortality from coronary heart disease mortality in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
3. Laing SP, Swedlow AJ, Slater DS, et al. The British diabetic association cohort study II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 466-471, DOI: 10.1046/i.1464-5491.1999-00076.x.
4. Kojda G, Harrison D. Interaction between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and health failure. Cardiovasc Res 1999; 43: 562-571, DOI:10.1016/SO008-6363(99)00169-8.
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844.
6. Santini SA, Marra G, Giardina B, et al. Defective plasma antioxidant defenses and enhanced: susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997; 46: 1853-1858.
7. Marra G, Cotroneo P, Pitocco D, et al. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 2002; 25: 370-375.
8. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-2018.
9. Rubbo H, Darley-Usmar V, Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996; 9: 809-820, DOI: 10.1021/tx960037q.
10. Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309-316, DOI: 10. 1006/abbi. 1996.0178.
11. Lepoivre M, Flaman J, Bobe P, Lemaire G, Henry Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem 1994; 269: 21891-21897.
12. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Meth Enzymol 1994; 233: 229-240.
13. Hassoun PM, Yu FS, Zulueta JJ, White AC, Lanzillo JJ. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am J Physiol 1995; 268: L809-L817.
14. Cote CG, Yu FS, Zulueta JJ, Vosatka RJ, Hassoun PM. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol 1996; 271: L869-L874.
15. Lee C, Liu X, Zweier JL. Regulation of xanthine oxidase by nitric oxide and peroxynitrite. J Biol Chem 2000; 275: 9369-9376.
16. Stephenson J, Fuller JH, for the EURODIAB Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-285, DOI: 10.1007/s001250050106.
17. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Meth Enzymol 1994; 234: 279-293.
18. Tavazzi B, Lazzarino G, Leone P, et al. Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clin Biochem 2005; 38: 997-1008, DOI: 10.1016/j.clinbiochem.2005.08.002.
19. Romitelli F, Santini SA, Chierici E, et al. Comparison of nitrite/ nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: The importance of a correct removal of proteins in the Griess assay. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 851: 257-267, DOI: 10.1016/j.jchromb.2007.02.003.
20. Cotroneo P, Manto A, Todaro L, et al. Hyperfiltration in patients with type I diabetes mellitus: a prevalence study. Clin Nephrol 1998; 50:214-217.
21. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862.
22. Sevanian A, Davies KJ, Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 1991; 54(Suppl. 6): 1129S-1134S.
23. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993; 14: 615-631, DOI: 10.1016/ 0891-5849(93)90143-1.
24. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in IDDM. Diagn Pathol 2007; 2: 22.
25. Hoeldtke RD. Nitrosative stress in early Type 1 diabetes. Clin Auton Res 2003; 13: 406-421, DOI: 10.1007/s10286-003-0139-X.
26. Soriano FG, Virag L, Jagtap P, et al. Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med 2001; 7: 108-113, DOI: 10.1038/83241.
27. Cooke CM, Davidge ST. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 2002; 282: C395-C402, DOI: 10.1152/ ajpcell.00295.2001.
28. Santos C, Anjos E, Augusto O. Uric acid oxidation by peroxynirite: multiple reactions, Free radical formation and amplification of lipid oxidation. Arch Biochem Biophys 1999; 372: 285-294.
29. - imbalance in insulin resistant rat aorta. Diabetes 1999; 48: 2437-2445.
30. Meininger CJ, Marinos RS, Hatakeyama K, et al. Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 2000; 349: 353-3S6.
31. Nieto F, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148: 131-139, DOI: 10.1016/ S0021-9150(99)00214-2.
32. Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001; 38: 1850-1857, DOI: 10.1016/S0735-1097(01)01643-6.
33. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006; 55: 3127-3132, DOI: 10.2337/ db06-0283.